AFGYF yields 1428.57% · JNJ yields 2.13%● Live data
📍 AFGYF pulled ahead of the other in Year 1
Combined, AFGYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AFGYF + JNJ for your $10,000?
AFC Energy plc engages in the development of alkaline fuel cell technology and allied equipment for the generation of clean energy in the United Kingdom. The company offers HydroX-Cell(L), an alkaline fuel cell module; HydroX-Cell(S); and AlkaMem, an anionic exchange membrane technology for alkaline water electrolysis, alkaline fuel cells, fuel synthesis, electrodialysis, desalination, acid remediation, salt water batteries, and REDOX flow batteries applications. It also provides auxiliary equipment, such as ammonia crackers, water electrolyzes, invertors, battery and fuel storage products, and battery management systems. The company sells its products for industrial applications, such as mobility, construction and temporary power, maritime, data centres, and rail. The company was incorporated in 2006 and is headquartered in Cranleigh, the United Kingdom.
Full AFGYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.